Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 976 results for "us food and drug administration"

FDA Approves Pelvalon's Eclipse Vaginal Insert for Fecal Incontinence
Med India

NEWRON PHARMACEUTICALS : Xadago® (safinamide) New Drug Applic...

Xadago® (safinamide) New Drug Application (NDA) Accepted for Filing by the U.S. Food and Drug Administration (FDA) Xadago ® under review as an add-on therapy for patients with early- to late-stage Parkinson's disease PDUFA date by ... 4 Traders, 1 hour ago
[x]  

457 images for us food and drug administration

1440 WNFL, 1 week ago
FOX 5 KVVU-TV, 1 week ago
Reuters, 4 hours ago
Yahoo! News, 4 hours ago
San Francisco Chronicle, 3 days ago
Irish Times, 3 weeks ago
The Fiscal Times, 3 weeks ago
Money Today, 3 weeks ago
seattlepi.com, 1 week ago
CBC, 1 week ago
Reuters

Why we should all be thrilled about the FDA starting to embrace innovation

19, the U.S. Food and Drug Administration took a huge step towards patient-centric medicine when it approved the marketing of genetics testing company 23andMe's carrier test for Bloom Syndrome. This was a startling - and good - development because ...
 Austin American Statesman4 hours ago Actavis and Medicines360 get FDA approval for pregnancy prevention drug Liletta  Pharmaceutical Business Review6 hours ago Allergan's gel-filled breast implants receives FDA approval  Medical Devices Business Review6 hours ago Sanofi Receives FDA Approval of Once-Daily Basal Insulin Toujeo  Bionity.com11 hours ago
[x]  
Reuters

Oncolytics Gets Orphan Drug Designation From FDA For Cancer Of Fallopian Tube

Oncolytics Biotech Inc. (ONCY: Quote,ONC.TO: Quote) said Monday that the U.S. Food and Drug Administration or FDA has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of cancer of the fallopian tube. The ...
 RTTNews.com5 hours ago FDA OKs trials for experimental Ebola drug to begin in Liberia  FierceHomelandSecurity24 minutes ago Oncolytics drug gains third orphan drug designation  Stockwatch4 hours ago Oncolytics' REOLYSIN granted FDA Orphan Drug Designation for treatment of fallopian tube cancer  News-Medical.Net4 hours ago
[x]  
This Day Online

NAFDAC Arrests Indian for Importing Fake Goods

Dr. Paul Orhii, DG of NAFDAC Chiemelie Ezeobi The National Agency for Food and Drug Administration and Control (NAFDAC), Saturday arrested an Indian national, Prakarsh Mohinani, in Rivers state for importing and distributing fake and ...
 This Day Online1 day ago

U.S. Food and Drug Administration Accepts Supplemental Biologics License Application for Yervoy® (ipilimumab) as Adjuvant Treatment for Patients with Stage 3 Melanoma Who Are at High Risk of Recurrenc

Bristol-Myers Squibb Company ( NYSE:BMY ) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review the supplemental Biologics License Application (sBLA) for Yervoy for the ...
 CEOWorld Magazine2 hours ago FDA accepts Bristol-Myers' BLA for Opdivo to treat advanced squamous NSCLC  Pharmaceutical Business Review6 hours ago Bristol Myers Squibb : U.S. Food and Drug Administration Accepts Supplemental Biologics License Application for Yervoy® (ipilimumab) as Adjuvant Treatment for Patients with Stage 3 Melanoma Who Are at High Risk of Recurrence  4 Traders2 hours ago Press Release: U.S. Food and Drug Administration Accepts Supplemental Biologics License Application for Yervoy(R) (ipilimumab) as Adjuvant Treatment for Patients with Stage 3 Melanoma Who Are at High Risk of Recurrence  iMarketReports2 hours ago
[x]  

Shire : FDA Application For Approval Of Lifitegrast For Dry Eye Disease

SAINT HELIER ( Alliance News ) - Shire PLC on Monday said it has submitted a New Drug Application or NDA with the US Food and Drug Administration for its investigational compound Lifitegrast for the treatment of signs and symptoms of dry eye disease ...
 4 Traders4 hours ago Shire Submits Application to the U.S. FDA for Approval of Lifitegrast for Treatment of Dry Eye Disease in Adults  Wall Street Select5 hours ago Shire Submits Application For FDA Approval Of Lifitegrast For Dry Eye Disease  RTTNews.com4 hours ago SHIRE : Submits Application to the U.S. FDA for Approval of Lifitegrast for Treatment of Dry Eye Disease in Adults  4 Traders5 hours ago
[x]  

Jubilant Life Sciences receives ANDA approval for Montelukast

Jubilant Life Sciences has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (USFDA) for Montelukast Sodium Chewable Tablets, 4 mg and 5 mg, the generic version of Singulair Chewable Tablets (of Merck), ...
 Money Control6 hours ago Jubilant Life gets USFDA nod for generic anti—asthma tablets  Hindu Business Line4 hours ago Jubilant Life Sciences gets ANDA nod for Montelukast  MyIris5 hours ago Jubilant Life gets USFDA nod for normal anti-asthma tablets  Moneycontrol.com2 hours ago
[x]  

FDA Grants Priority Review For Asfotase Alfa As Treatment For Patients With HPP

Alexion Pharmaceuticals Inc. (ALXN: Quote) announced that the U.S. Food and Drug Administration or FDA has accepted for Priority Review the Company's Biologics License Application or BLA for asfotase alfa, an investigational, first-in-class enzyme ...
 RTTNews.com5 hours ago
My.NewsHub.org

FDA rejects Pacira's application for expanded use of pain drug

REUTERS: The U.S. Food and Drug Administration rejected Pacira Pharmaceuticals Inc's application for expanding the use of its pain drug, exparel. Exparel is currently used to manage post-surgical pain at the site of an operation and Pacira sought ...
 Channel NewsAsia4 hours ago Shares Fall as the FDA Rejects Pacira Pharmaceuticals, Inc. (PCRX)'s Application for Expanded Use of Pain Drug 3/2/2015  ClinicSpace3 hours ago UPDATE 1-FDA rejects Pacira's application for expanded use of pain drug  Reuters Africa4 hours ago Pozen says FDA rejects two forms of its lead drug, shares fall  Reuters2 months ago
[x]  

Neuren Pharmaceuticals Limited receives FDA response to request for Breakthrough Therapy

4:00pm EST Neuren Pharmaceuticals Limited:Says that the US Food and Drug Administration (FDA) has responded to Neuren's request for Breakthrough Therapy designation for trofinetide to treat Rett syndrome.The FDA agreed that Rett syndrome meets the ...
 Reuters12 hours ago Neuren Pharmaceuticals : receives response to request for Breakthrough Therapy  4 Traders18 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - us food and drug administration
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less